Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

Cough-Medicine Dilemma Widens

Source: online.wsj.com
November 1, 2007
We don't treat colds, we treat children
Author: GLG Expert Contributor
The data is lacking for efficacy, and mis-use is associated with safety issues. On the other hand, there is (admittedly inadequate) anecdotal experience which suggests at least some benefit.
Tim GallagherNovember 1, 2007
Should We Treat Colds In Children?
Author: Tim Gallagher, RPh, Executive Vice President of Pharmacy Operations , Astrup Drug, Inc.
An FDA advisory panel recently voted to stop the recommendation of otc cough and cold products in children less than 12 years of age. For decades parents have administered otc cough and could products to infants and young children. Even the FDA Advisory Committee had dissention amongst their members, voting 13 to 9 in favor of the change in the long standing treatment protocol of children's colds

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T13:45:22.747